Rb-loss is associated with high malignancy in chondrosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Loss of function of the human retinoblastoma gene (Rb) is a frequent genetic abnormality in human malignancies.
• Rb gene dysfunction disrupts cell cycle control, leading to abnormal proliferation and differentiation.

Purpose of the Study:

• To investigate the loss of heterozygosity (LOH) of the Rb gene in various cartilaginous tumors.
• To correlate Rb-LOH status with Rb protein expression via immunohistochemistry.

Main Methods:

• Polymerase chain reaction (PCR) was used to detect Rb-LOH in 31 formalin-fixed, paraffin-embedded cartilaginous tumors.
• Tumors included dedifferentiated chondrosarcoma, conventional chondrosarcoma (grades 1-3), enchondromas, and chondroblastomas.
• Microdissection separated components of dedifferentiated chondrosarcoma; Rb protein expression was assessed by immunohistochemistry.

Main Results:

• Rb-LOH was detected in one grade 3 chondrosarcoma and in the anaplastic component of 7 out of 8 dedifferentiated chondrosarcomas (89%).
• All tumors with Rb-LOH showed negative Rb immunohistostaining.
• Benign tumors and low-grade chondrosarcomas were negative for Rb-LOH and positive for Rb protein expression.

Conclusions:

• Rb-LOH predominantly occurs in high-grade chondrosarcomas, especially dedifferentiated types.
• Rb-LOH is associated with loss of Rb protein expression in high-grade tumors.
• Rb-LOH is not a reliable marker for predicting progression or recurrence in low-grade cartilaginous tumors.